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Abstract A number of women with migraine experience
increased incidence of attacks during the perimenstrual
period. The Appendix of the International Classification of
Headache Disorders (ICHD II) describes two types of
migraine without aura related to menstruation: pure men-
strual migraine (PMM) and menstrually related migraine
(MRM). The phrase ‘‘menstrual migraine’’ is often used to
cover both PMM and MRM. Although menstrual migraine is
well recognized, further scientific evidence is needed before
these definitions can be formally included in the ICHD III.
The aim of the present study was to investigate the preva-
lence of PMM and MRM in the general population in Nor-
way. The survey included 15,000 women, 30–44 years old,
residing in the eastern part of Norway. They received a
postal questionnaire containing six questions about
migraine, headache frequency and the relation of migraine
and menstruation. The study included 11,123 women. The
questionnaire response rate was 77%. The prevalence of
self-reported migraine was 34.8%. Of the migraineurs, 21%
reported migraine related to menstruation in at least two of
three menstrual cycles, of which 7.7% were considered to
have PMM and 13.2% MRM. This corresponds to the
prevalence of PMM and MRM in the general population of
2.7 and 4.6%, respectively. Thus, self-reported menstrual
migraine among women aged 30–44 years appears to be
common in the general population in Norway.
Keywords Menstrual migraine  Prevalence 
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Introduction
The prevalence of migraine prior to puberty is 4% in boys
and girls [1]. After menarche and during women’s repro-
ductive years, the prevalence increases significantly more
in women than in men, and so the male: female ratio shifts
from 1:1 to 1:2–3 [2–4]. Migraine onset is associated with
menarche [5] and often declines after menopause [6]. More
than 50% of women with migraine, both in the general
population and presenting to headache clinics, report
an association between menstruation and migraine [7, 8];
7–14% experience attacks only during menstruation [9–13].
The International Classification of Headache Disorders
II (ICDH II) defines the criteria for pure menstrual
migraine (PMM) and menstrually related migraine (MRM)
in the Appendix [14]. PMM is defined as migraine without
aura that occurs exclusively on day 1 ± 2 of menstruation
in at least two out of three menstrual cycles. MRM has
additionally attacks of migraine without aura beyond the
perimenstrual period. The term ‘‘menstrual migraine’’ is
often used to describe both PMM and MRM together.
Although the two types of migraine related to menstruation
are likely to be distinct subtypes of migraine without aura,
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further scientific evidence is needed before these terms can
formally be accepted in the future ICHD III.
Previous studies indicate that attacks of PMM and MRM
are more severe, longer lasting, less responsive to acute
treatment and give a higher work-related disability than
non-menstrual attacks [15, 16]. Despite this fact, PMM and
MRM often remain under-recognized and under-treated by
general practitioners and neurologists. Few studies provide
information on the prevalence of menstrual migraine in the
general population, and the prevalence varies significantly
in different studies.
The aim of our study was to estimate the prevalence of
self-reported migraine, PMM and MRM, among women
aged 30–44 years from the general Norwegian population.
Methods
Sampling
This was a retrospective cross-sectional study based on an
age-stratified sample of 15,000 women, 30–44 years old,
residing in the eastern Akershus County in Norway.
The sample was drawn from the National Personal Regis-
try. Since this was a part of ‘‘The Akershus study of
chronic headache’’, this age limit was defined in advance
[17, 18].
Akershus County has both rural and urban areas and is
situated in close proximity to Oslo. Data from Statistics
Norway shows that the sampling area was representative of
the total Norwegian population regarding age and marital
status. Employment, trade, hotel/restaurant and transport
were overrepresented, whereas industry, oil and gas and
financial services were under-represented in the sampling
area compared with the total Norwegian population (Statis-
tics Norway, 2007; http://statbank.ssb.no/statistikkbanken/).
The total population of the sampling area was 338,670,
which is 7.4% of the Norwegian population. Our sample
represents 36.6% of women in this age group in the eastern
municipalities of Akershus County and 2.9% of women in
Norway.
Questionnaire
The women received a short screening questionnaire with a
standard letter containing information about the project.
Apart from insuring confidentiality and emphasizing the
importance of participation, it was stated that the object
was to study headache. The questionnaire included ques-
tions about headache frequency within the last month and
year, migraine within the last year and earlier, and whether
the migraine was associated with menstruation and, if so,
how often it occurred in relation to menstruation. If the
questionnaire evoked no response, a second and subse-
quently a third mail were issued.
Classification
The ICHD II appendix criteria for PMM (A1.1.1) and MRM
(A 1.1.2) were used [14]. Women with self-reported
migraine and self-reported migraine in at least two of three
menstrual periods were classified as ‘‘menstrual migraine’’,
i.e., PMM or MRM. PMM was defined as migraine without
aura that occurred exclusively on day 1 ± 2 of menstruation
in at least two out of three menstrual cycles. MRM had
additionally attacks of migraine without aura outside the
perimenstrual period. The median length of the menstrual
cycle was 28 days (usual range, 25–36 days), which gives
10–14 menstrual periods a year [19]. The mean duration of a
menstrual migraine attack has been estimated at 33.7 h [16].
Thus, we classified women who reported in at least two out of
three cycles B6 days of headache in the last month and
B30 days of headache in the last year as having PMM, while
the remaining women were classified as having MRM.
Since the relation of migraine and menstruation cannot
be established with certainty in women with chronic
headache, i.e., C15 headache days within the last month or
C180 headache days within the last year, we excluded
these women from the analysis. The analyses of migraine
prevalence were based on all who had a positive response
to the question about ever having had migraine.
Data processing and statistical methods
All questionnaires were scanned using TeleForm v9. Sta-
tistical analyses were performed using SPSS Base System for
Windows 15.0 (SPSS Inc., Chicago, IL, USA). Prevalence
rates were calculated using the Vassar College statistics Web
page and are presented with 95% confidence intervals (2009;
http://faculty.vassar.edu/lowry/VassarStats.html).
Ethical issues
The Regional Committees for Medical Research Ethics and
the Norwegian Social Science Data Services approved the
project. Participation was based on informed consent.
Results
Figure 1 is a flowchart of the population-based sample. The
sample size was reduced to 14,436 because of error in the
address list (n = 535), emigration (n = 19), multi-handicap
(n = 9) and death (n = 1). The overall response rate of the
questionnaire was 77% (11 123/14 436). The questionnaire
response rate among women within the three age groups, 30–
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34, 35–39 and 40–44 years, increased significantly with age
(73, 77 and 81%; P \ 0.001). Information regarding head-
ache in the last month and year, migraine previously and
within the last year, migraine related to menstruation and
frequency of migraine related to menstruation were missing
in 0.2% (17/11 123), 0.4% (39/11 123), 1.0% (107/11 123),
1.5% (162/11 123), 2.0% (223/11 123) and 2.2% (43/1 927)
of the questionnaires. Excluding those with chronic head-
ache (617) and those with missing information about
migraine previously and migraine in relation to menstruation
reduced the study sample to 10,176 women.
Prevalence of pure menstrual migraine and menstrually
related migraine
The prevalence of self-reported migraine was 34.8% (3
552/10 176). Among the migraineurs, 21% (746/3 552) had
self-reported migraine in relation to menstruation, of which
7.7% (275/3 552) had PMM and 13.2% (471/3 552) had
MRM. The prevalence of PMM and MRM in the general
population was 2.7% (275/10 176) and 4.6% (471/10 176),
respectively. The prevalence of self-reported migraine,
PMM and MRM, increased with age (Table 1).
Discussion
Strengths and limitations
Our large population-based sample of women and the high
questionnaire response rate provide population-based data
on menstrual migraine from the general Norwegian popu-
lation. Questionnaires are generally not valid for diagnos-
ing migraine and headache [20]. However, simple
questions such as: ‘‘Have you ever had migraine?’’, ‘‘How
many headache days did you experience within the last
month?’’ and ‘‘How many headache days did you experi-
ence within the last year?’’ are valid, as comparison with
physician-conducted interviews showed high j values of
0.77–0.81 [20–22]. As this was an epidemiological survey
on headache, headache may be over-represented among
responders of the questionnaire. We were not able to
investigate whether responder and non-responders had a
similar migraine and headache pattern, since for ethical
reasons we were not allowed to contact non-responders.
However, a Danish epidemiological survey based on a
short migraine screening questionnaire found no significant
difference in the frequency of migraine among responders
Sample
15 000
Study population
14 436
Responders
11 123
Complete information
about
menstrual migraine 10 793
Study sample
10 176
Migraine
3552
Menstrual migraine
746
Pure menstrual migraine
275
Not eligible
564
Non-responders
3313
Incomplete information
about menstrual migraine
330
Chronic headache
617
No migraine
6624
No menstrual migraine
2806
Menstrually related migraine
471
Fig. 1 Flowchart
Table 1 Results: lifetime prevalence of migraine and menstrual migraine
Age (years)
30–34 35–39 40–44 All
n = 3,245 (%) n = 3,410 (%) n = 3,521 (%) n = 10,176 (%)
Prevalence among all women
All migraine 33.3 (31.4–34.6) 35.1 (33.6–36.8) 36.1 (34.5–37.7) 34.9 (34.0–35.8)
Pure menstrual migraine 2.0 (1.6–2.6) 2.8 (2.3–3.3) 3.2 (2.8–3.8) 2.7 (2.4–3.0)
Menstrually related migraine 4.5 (3.8–5.2) 4.7 (4.0–5.4) 4.7 (4.0–5.4) 4.6 (4.2–5.0)
All menstrual migraine 6.6 (5.8–7.4) 7.5 (7.0–8.4) 7.8 (6.9–8.7) 7.3 (6.8–7.8)
Prevalence among migraineurs
Pure menstrual migraine 6.3 (4.9–7.8) 8.0 (6.5–9.5) 8.7 (7.2–10.2) 7.7 (6.9–8.7)
Menstrually related migraine 13.5 (11.5–15.5) 13.3 (11.3–15.3) 13.0 (11.0–15.0) 13.2 (12.1–14.3)
All menstrual migraine 19.8 (17.4–22.2) 21.4 (19.1–23.7) 21.7 (19.4–24.0) 20.9 (19.7–22.4)
The figure in parenthesis indicate 95% confidence interval
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and non-responders [21]. We included women aged 30–
44 years old, since this was a part of another study. Thus,
we did not have prevalence data on those who were
younger or older.
Our questionnaire did not enable the full set of criteria
for a precise ICHD II appendix diagnosis of PMM and
MRM. For that reason, we classified PMM and MRM
based on information of self-reported headache frequency.
Some women with PMM and co-occurrence of frequent
non-migraine headache might have been classified as
MRM in our sample. On the other hand, women with short
lasting attacks of MRM might have been classified as
PMM. The prevalence of PMM and MRM in our study can
therefore give a hint of the ‘‘true’’ prevalence. The golden
standard, a clinical interview and a headache diary, kept for
at least 3 months, would have given us the opportunity for
more precise headache diagnoses and prevalence estimates,
although such studies may suffer from non-compliance [23,
24].
The questions ‘‘Do you have migraine in relation to
menstruation?’’ and ‘‘How often do you have migraine in
relation to menstruation?’’ have not been validated. But
due to the fact that self-reported migraine and headache
frequency are valid questions, we assume that women with
migraine do know whether they have migraine in relation
to their menstruation as well as whether this occurs in all or
only some of the menstrual cycles.
The questionnaire does not distinguish between
migraine with and without aura. According to the ICHD-
classification, PMM and MRM are defined as migraine
without aura. We might have included some women with
migraine with aura, which may lead to a higher preva-
lence of PMM and MRM. However, migraine without
aura is 2.2 times more prevalent in women than migraine
with aura, which seldom occurs in relation to menstrua-
tion [2, 25] We do not have information about the use of
oral contraception, other hormonal treatment and preg-
nancy, which may influence the headache pattern of these
women. Furthermore, we have not investigated exactly on
which days of the menstrual period the migraine attacks
occurred and can therefore not be sure that the attacks of
migraine related to menstruation were exclusively on day
1 ± 2 according to the ICHD-definition. Because this was
a retrospective study, recall bias may play a role. Many
women have negative attitudes toward menstruation and
this influences their reports of menstrual symptoms,
including migraine. The more a woman believes in the
phenomenon of menstrual distress, the more she exag-
gerates the negativity of her symptoms. She is more likely
to recall inaccurately that menstrual-associated symptoms
are more severe than prospective diaries actually show
[26]. This might lead to a higher prevalence of menstrual
migraine than in reality.
Results
The lifetime prevalence of migraine in our female popu-
lation was 34.8%. This is similar to that found in other
epidemiological surveys of this age group conducted in
Sweden, Holland, Norway, USA and Germany [22, 27–30].
In another cross-sectional population-based survey per-
formed in the same county, as well as neighboring counties
in Norway, the lifetime prevalence of migraine in women
was 34.1% [22]. The prevalence of all menstrual migraine
among migraineurs was 21% in our study. This is similar to
figures from Danish and Swedish population-based studies
and an American clinic population of gynecologic/obste-
trician patients [2, 30, 31]. Our prevalence of pure PMM
was similar to British findings, applying almost the same
definition [10]. Our 13.2% prevalence of MRM corre-
sponds to the 10.1% prevalence in an American study,
while it is much lower than in most other studies, where the
prevalence varies between 35 and 71% [9–13, 30]. Our
results were based on a group of women with menstrual
migraine from which we subtracted those with assumed
PMM. Our data are based on mean attack duration of
33.7 h. However, if some of the women with PMM had
longer attacks, they might wrongly be assigned to the group
of those with MRM. Thus, our low prevalence of MRM is
not likely to be explained by our methods of calculation.
The large disparity in the prevalence may be due to the
former lack of a consistent definition of menstrual
migraine, different study populations and study design.
All of the studies listed below, with the exception of
two, were performed before the present definitions of PMM
and MRM were introduced to ICHD II (Table 2). In par-
ticular, the definition of MRM has been vague. There were
several women in our study (i.e., 717) who claimed to have
migraine related to menstruation, but had it less than in two
out of three menstrual cycles (i.e., ‘‘one out of two cycles’’
or ‘‘seldom’’). According to the definition, we did not
include these women. If they had been included, we would
have a prevalence of 41.2% (1 463/3 552), which is more
similar to studies conducted before the current definition.
Our prevalence in the general population of PMM and
MRM was 2.7 and 4.6%, respectively. These numbers are
higher than the results from a Dutch population-based
survey [15]. The studies are not directly comparable due to
different definitions of menstrual migraine and different
study samples (women with regular cycles vs. all women).
As much as 5.7% (617/10793) of the women were
excluded from our sample because of chronic headache.
Approximately 50% of women with chronic headache have
co-occurrence of migraine and only about 20% of them are
expected to have menstrual migraine [18]. The exclusion of
these women does not therefore make a substantial impact
on our prevalence of menstrual migraine.
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Conclusion
Menstrual migraine appeared to be common among women
aged 30–44 years old in the general population in Norway.
Improved knowledge from large prospective population-
based studies, with diary-confirmed diagnosis as well as
clinical trials for improved management is indicated.
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